REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07431086 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-12-28 → 2026-12-18 3. primary completion date: 2026-11-23 → 2026-11-13 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical